<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T3" position="float">
 <label>TABLE 3</label>
 <caption>
  <p>Engineered Tryptophan FDHs.</p>
 </caption>
 <table frame="hsides" rules="groups" cellspacing="5" cellpadding="5">
  <thead>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Brief description</td>
    <td valign="top" align="left" rowspan="1" colspan="1">References</td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" align="left" colspan="2" rowspan="1">
     <bold>Halogenase engineering studies</bold>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Tryptamine Position 7-targeting RebH mutant (Y455W).</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B42" ref-type="bibr">Glenn et al., 2011</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">PrnA mutant (F103A) with switched activity from a position 7 to a position 5 tryptophan halogenase.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B60" ref-type="bibr">Lang et al., 2011</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Improved functional RebH expression in 
     <italic>E. coli</italic> through co-expression of the bacterial chaperones GroEL/GroES. Improved functional RebF expression through fusion with maltose binding protein.
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B93" ref-type="bibr">Payne et al., 2013</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Thermostable RebH mutant (S2P, M71V, K145M, E423D, E461G, S130L, N166S, Q494R).</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B100" ref-type="bibr">Poor et al., 2014</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Collection of RebH mutants that chlorinate substrates that are not accepted by the wild type enzyme (including tricyclic tryptoline, large indoles, and carbazoles).</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B94" ref-type="bibr">Payne et al., 2015</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">RebH and PrnA mutants with expanded substrate scopes that include alternative aryl substrates.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B114" ref-type="bibr">Shepherd et al., 2015</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">SttH mutant (L460F/P461E/P462T) with switched activity from a position 6 to a position 5 tryptophan halogenase.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B115" ref-type="bibr">Shepherd et al., 2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Three RebH mutants chlorinating tryptamine at positions 5 (I52H, L380F, F465C, N470S, Q494R, R509Q), 6 (I52M, S110P, S130L, N166S, L380F, S448P, Y455W, F465L, N470S, Q494R, R509Q), or 7 (N470S) with regiospecificity of at least 90%.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B4" ref-type="bibr">Andorfer et al., 2016</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Bifunctional fusion enzyme consisting of a reductase (RebF) and a halogenase (RebH) showed improved yields of 7-chloro-tryptophan 
     <italic>in vivo</italic>.
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B3" ref-type="bibr">Andorfer et al., 2017</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">ThaL mutant (V52I, V82I, S360T, G469S, and S470N) with switched activity from a position 6 to a position 7 tryptophan halogenase.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B84" ref-type="bibr">Moritzer et al., 2019</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Thermostable ThaL mutant (S359G, K374L, I393V) with improved activity at 25 C.</td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B82" ref-type="bibr">Minges et al., 2020</xref>
    </td>
   </tr>
   <tr>
    <td valign="top" align="left" rowspan="1" colspan="1">Bifunctional fusion enzyme consisting of a reductase (Fre) and a halogenase (XanH) showed slightly elevated halogenase activity 
     <italic>in vitro</italic> compared to the two-component system.
    </td>
    <td valign="top" align="left" rowspan="1" colspan="1">
     <xref rid="B58" ref-type="bibr">Kong et al., 2020</xref>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <attrib>
   <italic>A tabulated summary of key studies reporting engineered halogenases that can be integrated into future MIA cell factories. With the exception of XanH, halogenases that do not target indole or tryptophan have been excluded.</italic>
  </attrib>
 </table-wrap-foot>
</table-wrap>
